The Real Chemistry Podcast · W2O Group

Cannesplaining Healthcare: Improving Patient Experiences Through Creativity & Innovation With President of Cannes Lions 2024 Pharma Jury, Collette Douaihy

·30 min·1 clip
Colette says Cannes Lions hand-picked jurors with deep pharma knowledge and judged on purpose, impact, and craft.
1. The Real Chemistry Podcast episode focuses on Cannesplaining Healthcare and Colette Douaihy's view of Cannes Lions 2024 pharma judging. 2. Aaron Strout hosts the conversation, Colette Douaihy joins as Global CCO at Dentsu Health and Jury President of Cannes Health, and Tom Richards and Chris Charles add the 21 Grams perspective. 3. The episode asks what makes pharma work "can-worthy" and how creativity, regulation, and patient experience can coexist. 4. Colette says Cannes Lions hand selected the jury for deep pharma knowledge, not just general health and wellness experience. 5. She says the criteria were purpose, lasting impression, impact, accuracy, and storytelling craft. 6. She repeats the question "is it can-worthy?" as the final test for the room. 7. Colette says the 2018 jury became "thick as thieves" after meals, drinks, swimming, and judging together. 8. She recalls the WhatsApp group "the best jury ever 2018" and the catchphrase "don't judge a judge." 9. Asked about her favorite work, she names Magnetic Stories and Voices of the World. 10. She also says Voice to Diabetes still "has a little ways to go" before it reaches the same level. 11. Colette points to Phexy, Freestyle Libre, and Under a Rock as pharma pieces that felt fresh in 2022 and 2023. 12. She describes Phexy's opening line, "Welcome to My Vagina," as hard to move through an MLR process. 13. She says Freestyle Libre turned ordinary moments like pizza and salad at a meeting into something memorable. 14. She says Under a Rock used set design, music, and idiom-based storytelling to make a familiar idea remarkable. 15. Colette says the biggest trend she saw was a rise in product innovation, customer experience, and inclusivity. 16. She argues for a wider aperture in pharma, using Parkinson's and scrolling therapy as examples of more human design. 17. The conversation is loose, collaborative, and full of back-and-forth from the three creative guests. 18. It moves between jury criteria, award examples, client education, and a final sandwich joke about a French dip. 19. People interested in pharma marketing, Cannes Lions, and healthcare creativity would likely value it. 20. People looking for a short, pure entertainment listen or narrative payoff may skip it.
Listen to the show on